AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own HCI Group, you need to believe in its tech-enabled underwriting via Exzeo and disciplined risk selection, even as its earnings outlook has turned more cautious. The June 2026-quarter setup, with a slightly lower earnings projection but a positive Earnings ESP and a Zacks Rank of #3, has not fundamentally changed the near term focus on potential margin resilience versus the ongoing concentration and catastrophe risks in Florida.
The most relevant recent announcement here is HCI’s addition to several Russell value indices, coinciding with its technology and underwriting story drawing more attention as a potential earnings surprise candidate. This reclassification aligns the stock more clearly with investors who prioritize profitability, capital discipline, and dividend plus buyback capacity as they weigh the impact of Florida exposure, reinsurance costs, and any future Exzeo separation on HCI’s risk and return profile.
But beneath the focus on a possible EPS beat, investors should also be aware of...
Read the full narrative on HCI Group (it's free!)
HCI Group's narrative projects $1.1 billion revenue and $197.3 million earnings by 2029.
Uncover how HCI Group's forecasts yield a $245.00 fair value, a 37% upside to its current price.
Three fair value estimates from the Simply Wall St Community span roughly US$238 to US$798 per share, highlighting sharply different views on HCI’s potential. You can weigh those opinions against the current focus on Exzeo driven underwriting and Florida catastrophe exposure, and consider how these could shape HCI’s future earnings resilience.
Explore 3 other fair value estimates on HCI Group - why the stock might be worth over 4x more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com